Valuation: Amedica Corporation

Market Cap 6.61M 5.74M 5.33M 4.92M 9.26M 631M 9.43M 63.11M 24.71M 313M 24.82M 24.27M 1.05B P/E 2026 *
-0.71x
P/E 2027 * -1.07x
Enterprise Value 6.61M 5.74M 5.33M 4.92M 9.26M 631M 9.43M 63.11M 24.71M 313M 24.82M 24.27M 1.05B EV / Sales 2026 *
2.87x
EV / Sales 2027 * 1.25x
Free-Float
75.59%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2007
President - 15/03/2026
Director of Finance/CFO 41 03/09/2025
Director TitleAgeSince
Director/Board Member 64 02/04/2025
Director/Board Member 72 04/11/2012
Director/Board Member 63 30/11/2007
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%+9.11%-13.08%+22.98% 133B
-2.18%+6.21%+1.54%-0.04% 13.43B
+4.24%+10.77%+79.18%+120.72% 9.94B
+3.30%+2.64%-43.13%-68.82% 4.8B
-0.52%+1.45%-0.87%+37.81% 2.67B
-3.17%+12.43%+8.40%-53.68% 1.69B
-0.99%+1.14%-18.51%-24.14% 1.66B
+0.30%+2.64%-26.45%-33.09% 1.65B
Average -0.03%+7.30%-1.62%+0.22% 21.16B
Weighted average by Cap. -0.82%+9.56%-7.13%+22.75%

Financials

2026 *2027 *
Net sales 2.3M 2M 1.86M 1.71M 3.23M 220M 3.29M 22M 8.61M 109M 8.65M 8.46M 367M 5.27M 4.58M 4.25M 3.92M 7.38M 503M 7.51M 50.3M 19.69M 250M 19.78M 19.35M 840M
Net income -12.38M -10.75M -9.98M -9.21M -17.35M -1.18B -17.66M -118M -46.28M -587M -46.48M -45.47M -1.97B -11.38M -9.88M -9.18M -8.46M -15.94M -1.09B -16.23M -109M -42.54M -539M -42.72M -41.79M -1.81B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-